UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

LRRK2 kinase in Parkinson's disease

Science (American Association for the Advancement of Science), 2018-04, Vol.360 (6384), p.36-37

2018

Volltextzugriff (PDF)

Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease

Current opinion in cell biology, 2020-04, Vol.63, p.102-113

2020

Volltextzugriff (PDF)

mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)

Biochemical journal, 2008-12, Vol.416 (3), p.375-385

2008

Volltextzugriff (PDF)

LKB1 and AMPK and the cancer-metabolism link - ten years after

BMC biology, 2013-04, Vol.11 (1), p.36-36, Article 36

2013

Volltextzugriff (PDF)

Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase

The EMBO journal, 2018-01, Vol.37 (1), p.1-18

2018

Volltextzugriff (PDF)

Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation

Nature communications, 2017-10, Vol.8 (1), p.830-14, Article 830

2017

Volltextzugriff (PDF)

The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling

PloS one, 2012-06, Vol.7 (6), p.e39132

2012

Volltextzugriff (PDF)

Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis

eLife, 2017-11, Vol.6

2017

Volltextzugriff (PDF)

Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors

Biochemical journal, 2016-09, Vol.473 (17), p.2671-2685

2016

Volltextzugriff (PDF)

LRRK2 activation in idiopathic Parkinson's disease

Science translational medicine, 2018-07, Vol.10 (451)

2018

Volltextzugriff (PDF)

Structural Basis for Rab8a Recruitment of RILPL2 via LRRK2 Phosphorylation of Switch 2

Structure (London), 2020-04, Vol.28 (4), p.406-417.e6

2020

Volltextzugriff (PDF)

The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters

Science signaling, 2014-07, Vol.7 (334), p.re3

2014

Volltextzugriff (PDF)

PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition

Cancer cell, 2016-08, Vol.30 (2), p.229-242

2016

Volltextzugriff (PDF)

Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites

Biochemical journal, 2021-01, Vol.478 (2), p.299-326

2021

Volltextzugriff (PDF)

The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters

Biochemical journal, 2014-03, Vol.458 (3), p.559-573

2014

Volltextzugriff (PDF)

14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization

Biochemical journal, 2010-09, Vol.430 (3), p.393-404

2010

Volltextzugriff (PDF)

Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors

Biochemical journal, 2013-06, Vol.452 (3), p.499-508

2013

Volltextzugriff (PDF)

Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer

Cancer cell, 2013-03, Vol.23 (3), p.406-420

2013

Volltextzugriff (PDF)

A pathway for Parkinson's Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain

eLife, 2018-11, Vol.7

2018

Volltextzugriff (PDF)

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases

eLife, 2016-01, Vol.5

2016

Volltextzugriff (PDF)

Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase

Biochemical journal, 2014-11, Vol.463 (3), p.413-427

2014

Volltextzugriff (PDF)

Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells

Gastroenterology (New York, N.Y. 1943), 2012-06, Vol.142 (7), p.1504-1515.e3

2012

Volltextzugriff (PDF)

Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)

Biochemical journal, 2009-06, Vol.421 (1), p.29-42

2009

Volltextzugriff (PDF)

Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils

Biochemical journal, 2018-01, Vol.475 (1), p.23-44

2018

Volltextzugriff (PDF)

The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human

Biochemical journal, 2018-06, Vol.475 (11), p.1861-1883

2018

Volltextzugriff (PDF)

1 – 25 von 375

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(365)
Mit Volltextzugriff
(340)

Publikationsform

Sprache

Englisch
(374)
Japanisch
(3)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(263)
Life Sciences & Biomedicine
(237)
Humans
(202)
Animals
(173)
Biochemistry & Molecular Biology
(155)
Phosphorylation
(130)
Mice
(111)
Cell Biology
(91)
Protein-Serine-Threonine Kinases - Metabolism
(72)
Mutation
(71)
Amino Acid Sequence
(70)
Molecular Sequence Data
(66)
Cell Line
(60)
Signal Transduction
(60)
Protein Serine-Threonine Kinases - Metabolism
(53)
Proteins
(48)
Kinases
(47)
3-Phosphoinositide-Dependent Protein Kinases
(44)
Parkinson's Disease
(44)
Enzyme Activation
(43)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

LRRK2 kinase in Parkinson's disease

Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease

mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)

LKB1 and AMPK and the cancer-metabolism link - ten years after

Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase

Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation

The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling

Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis

Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors

LRRK2 activation in idiopathic Parkinson's disease

Structural Basis for Rab8a Recruitment of RILPL2 via LRRK2 Phosphorylation of Switch 2

The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters

PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition

Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites

The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters

14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization

Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors

Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer

A pathway for Parkinson's Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases

Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase

Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells

Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)

Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils

The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human

Suchergebnisse filtern